Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism
-
'A den of bandits': Rwanda closes thousands of evangelical churches
-
Southeast Asia bloc meets to press Thailand, Cambodia on truce
-
As US battles China on AI, some companies choose Chinese
-
AI resurrections of dead celebrities amuse and rankle
-
Steelers receiver Metcalf strikes Lions fan
-
Morocco coach 'taking no risks' with Hakimi fitness
-
Gang members given hundreds-years-long sentences in El Salvador
-
Chargers, Bills edge closer to playoff berths
-
Gang members given hundred-years-long sentences in El Salvador
-
Hosts Morocco off to winning start at Africa Cup of Nations
-
No jacket required for Emery as Villa dream of title glory
-
Amorim fears United captain Fernandes will be out 'a while'
-
Nigerian government frees 130 kidnapped Catholic schoolchildren
-
Captain Kane helps undermanned Bayern go nine clear in Bundesliga
-
Captain Kane helps undermanned Bayern go nine clear
-
Rogers stars as Villa beat Man Utd to boost title bid
-
Barca strengthen Liga lead at Villarreal, Atletico go third
-
Third 'Avatar' film soars to top in N. American box office debut
-
Third day of Ukraine settlement talks to begin in Miami
-
Barcelona's Raphinha, Yamal strike in Villarreal win
-
Macron, on UAE visit, announces new French aircraft carrier
-
Barca's Raphinha, Yamal strike in Villarreal win
-
Gunmen kill 9, wound 10 in South Africa bar attack
-
Allegations of new cover-up over Epstein files
-
Atletico go third with comfortable win at Girona
-
Schwarz breaks World Cup duck with Alta Badia giant slalom victory
-
Salah unaffected by Liverpool turmoil ahead of AFCON opener - Egypt coach
-
Goggia eases her pain with World Cup super-G win as Vonn takes third
-
Goggia wins World Cup super-G as Vonn takes third
-
Cambodia says Thai border clashes displace over half a million
-
Kremlin denies three-way US-Ukraine-Russia talks in preparation
-
Williamson says 'series by series' call on New Zealand Test future
-
Taiwan police rule out 'terrorism' in metro stabbing
-
Australia falls silent, lights candles for Bondi Beach shooting victims
-
DR Congo's amputees bear scars of years of conflict
-
Venison butts beef off menus at UK venues
-
Cummins, Lyon doubts for Melbourne after 'hugely satsfying' Ashes
-
'It sucks': Stokes vows England will bounce back after losing Ashes
-
Australia probes security services after Bondi Beach attack
-
West Indies need 462 to win after Conway's historic century
-
Thai border clashes displace over half a million in Cambodia
-
Australia beat England by 82 runs to win third Test and retain Ashes
-
China's rare earths El Dorado gives strategic edge
-
Japan footballer 'King Kazu' to play on at the age of 58
-
New Zealand's Conway joins elite club with century, double ton in same Test
-
Australian PM orders police, intelligence review after Bondi attack
-
Durant shines as Rockets avenge Nuggets loss
-
Pressure on Morocco to deliver as Africa Cup of Nations kicks off
-
Australia remove Smith as England still need 126 to keep Ashes alive
-
Myanmar mystics divine future after ill-augured election
NYSE - LSE
Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism
CAMBRIDGE, MA / ACCESS Newswire / September 2, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that five abstracts on its investigational mRNA therapeutics have been accepted for presentation at the 2025 International Congress of Inborn Errors of Metabolism (ICIEM), which will be held September 2-6, 2025 in Kyoto, Japan, at the Kyoto International Conference Center. This includes three oral presentations and two poster presentations across the Company's propionic acidemia (PA), methylmalonic acidemia (MMA) and Glycogen Storage Disease Type 1a (GSD1a) programs. This is the first time Moderna will present data at a scientific congress for MMA and GSD1a.
The details of the presentations are as follows:
Oral Presentation #8 - Organic Acidemias: Clinical Burden of Propionic Acidemia in Japan: A real-world evidence cohort study using a hospital-based healthcare database
Time: Wednesday, September 3, 2025, 2:00 - 4:00 PM JST
Order of Presentation: 1
Location: Room 5
Presenter: Yoko Nakajima
Oral Presentation #8 - Organic Acidemias: mRNA-3705 Therapy for Methylmalonic Acidemia: Interim Data from a Phase 1/2 Study
Time: Wednesday, September 3, 2025, 2:00 - 4:00 PM JST
Order of Presentation: 7
Location: Room 5
Presenter: Sabine Fuchs
Oral Presentation #8 - Organic Acidemias: mRNA-3927 for the Treatment of Propionic Acidemia: Final results from mRNA-3927-P101 Part 1 dose-escalation cohorts and cumulative data from ongoing participants
Time: Wednesday, September 3, 2025, 2:00 - 4:00 PM JST
Order of Presentation: 8
Location: Room 5
Presenter: Andreas Schulze
Poster Presentation #P-521: Model-Informed Dose Selection for the Pivotal Study of mRNA-3705 in Methylmalonic Acidemia
Time: Wednesday, September 3, 2025, 6:00 - 7:00 PM JST
Location: Poster 1 - Annex Hall
Presenter: Min Liang
Poster Presentation #P-246: mRNA-3745 Therapy for GSD1a: Interim reported data from Phase 1/2 Ba1ance Study
Time: Thursday, September 4, 2025, 5:30 - 6:30 PM JST
Location: Poster 1 - Annex Hall
Presenter: Nicola Longo
About Moderna
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.
Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
Moderna Contacts
Media:
Chris Ridley
Head of Global Media Relations
+1 617-800-3651
[email protected]
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
+1 617-209-5834
[email protected]
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
M.Thompson--AMWN